Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells

Diabetes, Obesity and Metabolism

Volumn 16, Issue 11, 2014, Pages 1128-1139

  Moran, B M ^a   Abdel Wahab, Y H A ^a   Flatt, P R ^a   Mckillop, A M ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

GPR120; Insulin secretion; Lipid agonists; Type 2 diabetes; cells

Indexed keywords

ANTIDIABETIC AGENT; CYCLIC AMP; DOCOSAHEXAENOIC ACID; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 120 AGONIST; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; LACTATE DEHYDROGENASE; LINOLENIC ACID; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; GLUCOSE BLOOD LEVEL; O3FAR1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; AGONISTS; ANIMAL; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; METABOLISM; SECRETION (PROCESS);

ALPHA-LINOLENIC ACID; ANIMALS; BLOOD GLUCOSE; CELL LINE; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FEMALE; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; MICE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84914104945     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12330     Document Type: Article

References (48)

1. Hirasawa A, Tsumaya K, Awaji T et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11: 90-94.
2. Vangaveti V, Shashidhar V, Jarrod G, Baune BT, Kennedy RL. Free fatty acid receptors: emerging targets for treatment of diabetes and its complications. Ther Adv Endocrinol Metab 2010: 1-11.
3. Burns RN, Moniri NH. Agonism with the omega-3 fatty acids α-linolenic acid and docosahexaenoic acid mediates phosphorylation of both the short and long isoforms of the human GPR120 repector. Biochem Biophys Res Commun 2010; 396: 1030-1035.
4. Moore K, Zhang Q, Murgolo N, Hosted T, Duffy R. Cloning, expression, and pharmacological characterization of the GPR120 free fatty acid receptor from cynomolgus monkey: comparison with human GPR120 splice variants. Comp Biochem Physiol B 2009; 154: 419-426.
5. Gehrmann W, Elsner M, Lenzen S. Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β-cells. Diabetes Obes Metab 2010; 149: 149-158.
6. Dhayal S, Welters HJ, Morgan NG. Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic β-cell line, BRIN-BD11. Br J Pharmacol 2008; 153: 1718-1727.
7. Kebede MA, Alquier T, Latour MG, Poitout V. Lipid receptors and islet function: therapeutic implications? Diabetes Obes Metab 2009; 11: 10-20.
8. Matsumura S, Mizushige T, Yoneda T et al. GPR expression in the rat taste bud relating to fatty acid sensing. Biomed Res 2007; 28: 49-55.
9. Cartoni C, Yasumatsu K, Ohkuri T et al. Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci 2010; 30: 8376-8382.
10. Briscoe CP, Tadayyon M, Andrews JL et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 2003; 278: 11303-11311.
11. Brown AJ, Goldsworthy SM, Barnes AA et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003; 278: 11312-11319.
12. Briscoe CP, Peat AJ, McKeown SC et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small agonist. Br J Pharmacol 2006; 148: 619-628.
13. Shimpukade B, Hudson BD, Hovgaard CK, Milligan G. Discovery of a potent and selective GPR120 agonist. J Med Chem 2012; 55: 4511-4515.
14. Tanaka T, Yano T, Adachi T, Koshimizu T, Hirasawa A, Tsujimoto G. Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic β cells. Naunyn-Schmiedebergs Arch Pharmakol 2008; 377: 515-522.
15. Watson S, Brown AJH, Holliday ND. Differential signalling by splice variants of the human free fatty acid receptor GPR120. Mol Pharmacol 2012; 81: 631-642.
16. Milligan G, Stoddart LA, Brown AJ. G protein-coupled receptors for free fatty acids. Cell Signal 2006; 18: 1360-1365.
17. Hara T, Hirasawa A, Ichimura A, Kimura I, Tsujimoto G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J Pharm Sci 2011; 100: 3594-3601.
18. Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann GF. Nutrition-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 2009; 52: 289-298.
19. Iakoubov R, Izzo A, Yeung A, Whiteside CI, Brubaker PL. Protein kinase Cζ is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 2006; 148: 1089-1098.
20. Katsuma S, Hatae N, Yano T et al. Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. J Biol Chem 2005; 280: 19507-19515.
21. Gotoh C, Hong Y, Iga T et al. The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun 2007; 354: 591-597.
22. Ichimura A, Hirasawa A, Poulain-Godefroy O et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and humans. Nature 2012; 483: 350-357.
23. Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005; 45: 581-597.
24. Oh DY, Talukdar S, Bae EJ et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin sensitizing effects. Cell 2010; 142: 687-698.
25. Dhayal S, Morgan NG. Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin-secreting BRIN-BD11 cells. Br J Pharmacol 2011; 162: 1340-1350.
26. Hara T, Hirasawa A, Sun Q et al. Novel selective ligands for free fatty acid receptors GPR120 and GPR40. Naunyn-Schmiedebergs Arch Pharmakol 2009; 380: 247-255.
27. Sun Q, Hirasawa A, Hara T et al. Structure-activity relationships of GPR120 agonists based on docking simulation. Mol Pharmacol 2010; 78: 804-810.
28. Suzuki T, Igari S, Hirasawa A et al. Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists. J Med Chem 2008; 51: 7640-7644.
29. Rayasam GV, Tulasi VK, Davis JA, Bansal VS. Fatty acid receptors as new therapeutic targets for diabetes. Expert Opin Ther Targets 2007; 11: 661-671.
30. Hudson BD, Shimpukade B, Mackenzie AE et al. The pharmacology of a potent and selective agonist, TUG-891, demonstrates both potential opportunity and possible challenges to therapeutic agonism of FAR4 (GPR120). Mol Pharmacol 2013; 84: 1-54.
31. 35S]thio)triphosphate binding studies reflects binding of an endogenous agonist. Mol Pharmacol 2007; 71: 994-1005.
32. McClenaghan NH, Barnett CR, Ah-Sing E et al. Characterisation of a novel glucose-responsive insulin-secreting cell line, BRIN BD11, produced by electrofusion. Diabetes 1996; 45: 1132-1140.
33. Flatt PR, Bailey CJ. Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 1981; 20: 573-577.
34. Duffy NA, Green BD, Irwin N et al. Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1. Eur J Pharmacol 2007; 568: 278-286.
35. Moskalewski S. Studies on the culture and transplantation of isolated islets of Langerhans of the guinea pig. Proc K Ned Akad Wet C 1969; 72: 157-171.
36. Miguel JC, Patterson S, Abdel-Wahab YHA, Mathias PC, Flatt PR. Time-correlation between membrane depolarization and intracellular calcium in insulin secretion BRIN-BD11 cells: studies using FLIPR. Cell Calcium 2004; 36: 43-50.
37. Waters JC. Accuracy and precision in quantitative fluorescence microscopy. J Cell Biol 2009; 185: 1135-1148.
38. Mortensen K, Larsson L. Quantitative and qualitative immunofluorescence studies of neoplastic cells transfected with concurrent encoding p53-EGFP. J Histochem 2001; 49: 1363-1367.
39. Moran BM, Abdel-Wahab YH, Flatt PR, McKillop AM. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. Biol Chem 2014; 395: 453-464.
40. McKillop AM, Moran BM, Abdel-Wahab YHA, Flatt PR. Evaluation of insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. Br J Pharmacol 2013; 170: 978-990.
41. Araki T, Hirayama M, Hiroi S, Kaku K. GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes Obes Metab 2011; 14: 271-278.
42. Burant CF, Viswanathan P, Marcinak J et al. TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2012; 379: 1403-1411.
43. Zhao Y, Wang L, Zha D et al. GW9508 inhibits insulin secretion by activating ATP-sensitive potassium channels in rat pancreatic β-cells. J Mol Endocrinol 2013; 51: 69-77.
44. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm 2005; 288: 369-376.
45. Suresh Y, Das UN. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostag Leukotr Ess 2001; 64: 37-52.
46. Mobraten K, Haug TM, Kleiveland CR, Lea T. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but different kinetics and intensity in caco-2 cells. Lipids Health Dis 2013; 12: 1-7.
47. Sanchez-Reyes OB, Romero-Avila MT, Castillo-Badillo JA et al. Free fatty acids and protein kinase C activation induce GPR120 (free fatty acid receptor 4) phosphorylation. Eur J Pharmacol 2014; 723: 368-374.
48. Ou H, Wu H, Hung H, Yang Y, Wu J, Chang C. Multiple mechanisms of GW-9508, a selective G protein-coupled receptor 40 agonist, in regulation of glucose homeostasis and insulin sensitivity. Am J Physiol Endocrinol Metab 2013; 304: E668-676.